These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 7760310)
1. Piroxicam for bladder cancer. Barsanti JA J Vet Intern Med; 1995; 9(2):113-4. PubMed ID: 7760310 [No Abstract] [Full Text] [Related]
2. Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: a pilot study. Poirier VJ; Forrest LJ; Adams WM; Vail DM J Am Anim Hosp Assoc; 2004; 40(2):131-6. PubMed ID: 15007049 [TBL] [Abstract][Full Text] [Related]
3. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. Knapp DW; Richardson RC; Chan TC; Bottoms GD; Widmer WR; DeNicola DB; Teclaw R; Bonney PL; Kuczek T J Vet Intern Med; 1994; 8(4):273-8. PubMed ID: 7983623 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder. Greene SN; Lucroy MD; Greenberg CB; Bonney PL; Knapp DW J Am Vet Med Assoc; 2007 Oct; 231(7):1056-60. PubMed ID: 17916030 [TBL] [Abstract][Full Text] [Related]
5. Toxic effects and antitumor response of gemcitabine in combination with piroxicam treatment in dogs with transitional cell carcinoma of the urinary bladder. Marconato L; Zini E; Lindner D; Suslak-Brown L; Nelson V; Jeglum AK J Am Vet Med Assoc; 2011 Apr; 238(8):1004-10. PubMed ID: 21492043 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcome of partial cystectomy for transitional cell carcinoma of the canine bladder. Marvel SJ; Séguin B; Dailey DD; Thamm DH Vet Comp Oncol; 2017 Dec; 15(4):1417-1427. PubMed ID: 28217972 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of carbon dioxide laser ablation combined with mitoxantrone and piroxicam treatment in dogs with transitional cell carcinoma. Upton ML; Tangner CH; Payton ME J Am Vet Med Assoc; 2006 Feb; 228(4):549-52. PubMed ID: 16478428 [TBL] [Abstract][Full Text] [Related]
8. Retrospective evaluation of doxorubicin-piroxicam combination for the treatment of transitional cell carcinoma in dogs. Robat C; Burton J; Thamm D; Vail D J Small Anim Pract; 2013 Feb; 54(2):67-74. PubMed ID: 23286739 [TBL] [Abstract][Full Text] [Related]
9. Clinical Evaluation of Tavocept to Decrease Diuresis Time and Volume in Dogs with Bladder Cancer Receiving Cisplatin. Henry CJ; Flesner BK; Bechtel SA; Bryan JN; Tate DJ; Selting KA; Lattimer JC; Bryan ME; Grubb L; Hausheer F J Vet Intern Med; 2018 Jan; 32(1):370-376. PubMed ID: 29080252 [TBL] [Abstract][Full Text] [Related]
10. Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Mohammed SI; Craig BA; Mutsaers AJ; Glickman NW; Snyder PW; deGortari AE; Schlittler DL; Coffman KT; Bonney PL; Knapp DW Mol Cancer Ther; 2003 Feb; 2(2):183-8. PubMed ID: 12589035 [TBL] [Abstract][Full Text] [Related]
11. Transitional cell carcinoma of the urinary bladder in a 14-year-old dog. Caswell M Can Vet J; 2011 Jun; 52(6):673-5. PubMed ID: 22131588 [TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of piroxicam in spontaneous canine invasive urinary bladder cancer, a relevant model of human invasive bladder cancer. Knapp DW; Glickman NW; Mohammed SI; DeNicola DB; Widmer WR; Bonney PL; DeGortari AE Adv Exp Med Biol; 2002; 507():377-80. PubMed ID: 12664613 [No Abstract] [Full Text] [Related]
13. Cisplatin treatment of transitional cell carcinoma of the urinary bladder in dogs: 18 cases (1983-1993). Chun R; Knapp DW; Widmer WR; Glickman NW; DeNicola DB; Bonney PL J Am Vet Med Assoc; 1996 Nov; 209(9):1588-91. PubMed ID: 8899023 [TBL] [Abstract][Full Text] [Related]
14. Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development. Knapp DW; Ramos-Vara JA; Moore GE; Dhawan D; Bonney PL; Young KE ILAR J; 2014; 55(1):100-18. PubMed ID: 24936033 [TBL] [Abstract][Full Text] [Related]
15. Randomized phase III trial of piroxicam in combination with mitoxantrone or carboplatin for first-line treatment of urogenital tract transitional cell carcinoma in dogs. Allstadt SD; Rodriguez CO; Boostrom B; Rebhun RB; Skorupski KA J Vet Intern Med; 2015 Jan; 29(1):261-7. PubMed ID: 25619518 [TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder. McMillan SK; Boria P; Moore GE; Widmer WR; Bonney PL; Knapp DW J Am Vet Med Assoc; 2011 Oct; 239(8):1084-9. PubMed ID: 21985349 [TBL] [Abstract][Full Text] [Related]
17. Phase II clinical trial of carboplatin in canine transitional cell carcinoma of the urinary bladder. Chun R; Knapp DW; Widmer WR; DeNicola DB; Glickman NW; Kuczek T; Degortari A; Han CM J Vet Intern Med; 1997; 11(5):279-83. PubMed ID: 9348494 [TBL] [Abstract][Full Text] [Related]
18. [Transitional cell carcinoma of the urinary bladder of a dog]. Odendaal JS; Bastianello SS J S Afr Vet Assoc; 1982 Dec; 53(4):258-60. PubMed ID: 7182501 [TBL] [Abstract][Full Text] [Related]
19. Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder. Arnold EJ; Childress MO; Fourez LM; Tan KM; Stewart JC; Bonney PL; Knapp DW J Vet Intern Med; 2011; 25(6):1385-90. PubMed ID: 22092632 [TBL] [Abstract][Full Text] [Related]
20. Use of Toceranib Phosphate in the Treatment of Canine Bladder Tumors: 37 Cases. Gustafson TL; Biller B J Am Anim Hosp Assoc; 2019; 55(5):243-248. PubMed ID: 31433219 [No Abstract] [Full Text] [Related] [Next] [New Search]